Abstract
Genomic imbalances (GIs) are an important class of variation in the human genome. Many of them are related to diseases and responsible for the phenotype in a substantial number (10 - 20%) of individuals with congenital anomalies (CA) and (or) intellectual disability (ID)/ developmental delay (DD). Currently, the chromosomal microarray analysis (CMA) is pointed as a first tier for the mole…